Avillion, AstraZeneca asthma rescue treatment given FDA approval
pharmaphorum
JANUARY 12, 2023
Avillion – clinical co-development partner with AZ – conducted the global phase 3 trial of over 4,000 patients across four studies (including the MANDALA and DENALI trials). Additionally, under its 2018 agreement, Avillion had regulatory responsibility, including filing the New Drug Application (NDA) through to FDA approval.
Let's personalize your content